Aridis Pharmaceuticals (ARDS) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…

Aridis Pharmaceuticals (ARDS) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: April 29, 2025 (18:43)

Sector: Healthcare

The share price of Aridis Pharmaceuticals, Inc. (ARDS) now

Latest session on the 28th of April for
Aridis Pharmaceuticals, Inc. is negative
Trading Volume: 20000
Open: 0 /  High: 0 /  Low: 0

Are you interested in Aridis Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aridis Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Aridis Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Aridis Pharmaceuticals stock? When should I record a loss on Aridis Pharmaceuticals stock? What are analysts' forecasts for Aridis Pharmaceuticals stock? What is the future of Aridis Pharmaceuticals stock? We forecast Aridis Pharmaceuticals stock performance using neural networks based on historical data on Aridis Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aridis Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aridis Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Aridis Pharmaceuticals stock

The chart below shows the historical price of Aridis Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aridis Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Aridis Pharmaceuticals, Inc. Is a biopharmaceutical company specializing in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat infections. MABs represent a treatment approach that allows the human immune system to fight infections and is designed to overcome the disadvantages associated with current therapies, such as increased drug resistance, short response times, negative effects on the human microbiome, and lack of differentiation between treatment alternatives. Its product pipeline includes human MABs that target specific pathogens associated with bacterial infections, most notably hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Its leading candidate product, AR-301, targets the alpha toxin produced by the gram-positive bacteria Staphylococcus aureus, a common pathogen associated with HAP and VAP. Its AR-101 (Aerumab) is a fully human immunoglobulin M targeting P. aeruginosa serotype O11.

Trending Themes in the Healthcare Sector

Aridis Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 01 0.00 0.00 0.00 94.12
May 02 0.00 0.00 0.00 59.80
May 03 0.00 0.00 0.00 44.60
May 04 0.00 0.00 0.00 127.22
May 05 0.00 0.00 0.00 105.72
May 06 0.00 0.00 0.00 30.78
May 07 0.00 0.00 0.00 107.22
May 08 0.00 0.00 0.00 106.40
May 09 0.00 0.00 0.00 134.35
May 10 0.00 0.00 0.00 76.08
May 11 0.00 0.00 0.00 96.76
May 12 0.00 0.00 0.00 96.02
May 13 0.00 0.00 0.00 81.28
May 14 0.00 0.00 0.00 121.84
May 15 0.00 0.00 0.00 85.44
May 16 0.00 0.00 0.00 79.62
May 17 0.00 0.00 0.00 73.74
May 18 0.00 0.00 0.00 107.10
May 19 0.00 0.00 0.00 59.81
May 20 0.00 0.00 0.00 76.23
May 21 0.00 0.00 0.00 61.11
May 22 0.00 0.00 0.00 32.67
May 23 0.00 0.00 0.00 62.79
May 24 0.00 0.00 0.00 49.64
May 25 0.00 0.00 0.00 44.18
May 26 0.00 0.00 0.00 47.77
May 27 0.00 0.00 0.00 103.59
May 28 0.00 0.00 0.00 87.90
May 29 0.00 0.00 0.00 67.66
May 30 0.00 0.00 0.00 58.79

Aridis Pharmaceuticals Daily Price Targets


Aridis Pharmaceuticals Stock Forecast 05-01-2025.

Forecast target price for 05-01-2025: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 48.485%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Aridis Pharmaceuticals Stock Forecast 05-02-2025.

Forecast target price for 05-02-2025: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 37.423%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Aridis Pharmaceuticals Stock Forecast 05-03-2025.

Forecast target price for 05-03-2025: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 30.845%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Aridis Pharmaceuticals Stock Forecast 05-04-2025.

Forecast target price for 05-04-2025: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 55.991%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Aridis Pharmaceuticals Stock Forecast 05-05-2025.

Forecast target price for 05-05-2025: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 51.390%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Aridis Pharmaceuticals Stock Forecast 05-06-2025.

Forecast target price for 05-06-2025: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 23.537%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

ARDS (ARDS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
May. 0.00 0.00 0.00 13.31
Jun. 0.00 0.00 0.00 16.26
Jul. 0.00 0.00 0.00 15.29
Aug. 0.00 0.00 0.00 15.11
Sep. 0.00 0.00 0.00 16.88
Oct. 0.00 0.00 0.00 12.83
Nov. 0.00 0.00 0.00 10.39
Dec. 0.00 0.00 0.00 16.52

Aridis Pharmaceuticals forecast for this year


Aridis Pharmaceuticals Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $0.00010192. Pessimistic: $0.00. Optimistic: $0.00


Aridis Pharmaceuticals Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $0.000116107. Pessimistic: $0.00. Optimistic: $0.00


Aridis Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $0.00012391. Pessimistic: $0.00. Optimistic: $0.00


Aridis Pharmaceuticals Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $0.000124901. Pessimistic: $0.00. Optimistic: $0.00


Aridis Pharmaceuticals Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $0.000116707. Pessimistic: $0.00. Optimistic: $0.00


Aridis Pharmaceuticals Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $0.000131833. Pessimistic: $0.00. Optimistic: $0.00


Aridis Pharmaceuticals Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $0.000133731. Pessimistic: $0.00. Optimistic: $0.00


Aridis Pharmaceuticals Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $0.000143788. Pessimistic: $0.00. Optimistic: $0.00



Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.00 0.00 0.00 22.19
Feb 0.00 0.00 0.00 16.23
Mar 0.00 0.00 0.00 18.43
Apr 0.00 0.00 0.00 21.28
May 0.00 0.00 0.00 15.66
Jun 0.00 0.00 0.00 21.79
Jul 0.00 0.00 0.00 21.06
Aug 0.00 0.00 0.00 13.86
Sep 0.00 0.00 0.00 11.43
Oct 0.00 0.00 0.00 15.38
Nov 0.00 0.00 0.00 16.42
Dec 0.00 0.00 0.00 14.56

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.00 0.00 0.00 10.27
Feb 0.00 0.00 0.00 19.91
Mar 0.00 0.00 0.00 15.03
Apr 0.00 0.00 0.00 19.91
May 0.00 0.00 0.00 14.66
Jun 0.00 0.00 0.00 10.17
Jul 0.00 0.00 0.00 17.57
Aug 0.00 0.00 0.00 21.18
Sep 0.00 0.00 0.00 19.42
Oct 0.00 0.00 0.00 11.89
Nov 0.00 0.00 0.00 18.86
Dec 0.00 0.00 0.00 20.31

Aridis Pharmaceuticals information and performance

Aridis Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Aridis Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ARDS shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Aridis Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Aridis Pharmaceuticals Stock)

Should I Buy Aridis Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $0.00, which is $0.00 higher than the current stock price. By investing in Aridis Pharmaceuticals shares today for a one-year period, you could achieve a profit of 49.37%. With an investment horizon of up to two years, the target share price is $0.00. resulting in a profit of 32.88% ($0.00 per share).

Does Aridis Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Aridis Pharmaceuticals's shares belong to?

Aridis Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Aridis Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Aridis Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.